Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
Clinical trial NCT02058602 · COMPLETED
Trial details
- NCT number
- NCT02058602
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-03
- Primary completion
- 2016-07-11
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.